FDA Challenged to Address New Turn in Opioid Addiction Crisis – Details Here!
By: Scott Gottlieb, M.D.
The opioid epidemic has reached tragic proportions. Yet it continues to take many new, and troubling turns. If there’s one lesson we’ve learned from this crisis, it has been the ability of the mounting abuse and misuse to evade our interventions. This history challenges us to deal more quickly and aggressively when new aspects of the addiction crisis emerge. For example, we’re seeing a crisis that began largely with the misuse of prescription opioids evolve into an epidemic that’s increasingly being driven by an influx of street drugs like illicit fentanyl and heroin. We must be alert to these new patterns of abuse and misuse of different drugs.
One such concern relates to the inappropriate use of loperamide – an FDA-approved drug to help control symptoms of diarrhea, including travelers’ diarrhea. Loperamide is sold under its over-the-counter (OTC) brand name Imodium A-D, as store brands and as a prescription drug. Loperamide is an opioid agonist, and it’s safe and effective at its approved doses. The drug acts locally, inside the gut, to treat the symptoms of diarrhea.
But when loperamide is abused and taken at extremely high doses, some of it can cross the gut lining, giving users an opioid like “high.” We’re aware that those suffering from opioid addiction see loperamide as a potential alternative to manage opioid withdrawal symptoms or to achieve euphoric effects. But at these very high doses, it’s also dangerous.
Read the entire blog at FDA Voice.
You may be interested
Black Tech turns down $2.5 Billion to lift up Blacks in Technologyameliaismore - March 15, 2021
By Ameliaismore In the world of…
New Luxury Corporate Travel During the 2020-21 Pandemicameliaismore - March 15, 2021
by Jean-Hans Fulcher & CharLena Pearson Are you having…
Dance is to Michael Chambers what Moonwalk is to Michael Jackson…ameliaismore - March 15, 2021
By Jori Jordon …